Cloning and the Debate on Abortion
By Nigel Cameron and Lori Andrews,
Chicago Tribune
| 08. 08. 2001
Italian fertility specialist Severino Antinori has announced
that he will begin human cloning in early 2002. Two hundred
couples desperately seeking to create children will become human
guinea pigs in a massive experiment. The odds are not in their
favor. In animals, cloning currently only results in a successful
pregnancy 3 to 5 percent of the time. And, even in those rare
instances, many of the resulting offspring suffer. One-third
die shortly before or right after birth. Other cloned animals
seem perfectly healthy at first and then suffer heart and blood
vessel problems, underdeveloped lungs, diabetes, immune system
deficiencies and severe growth abnormalities.
If an infectious disease were killing one-third of human infants,
we would declare it a public health emergency. We certainly
wouldn’t set up a clinic to enable it to happen. Yet despite
these grave risks, only five states have laws banning human
cloning. There is no federal law on the subject yet. Despite
widespread public opposition to human cloning, various researchers
and biotech companies have so far prevented the passage of such
a law.
This summer, however...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Eric Schmidt, TIME | 04.16.2024
Imagine a world where everything from plastics to concrete is produced from biomass. Personalized cell and gene therapies prevent pandemics and treat previously incurable genetic diseases. Meat is lab-grown; enhanced nutrient grains are climate-resistant. This is what the future could...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...